Brain47Brain47Join Brain47
3M4

Masimo Corporation

Healthcare · EUR · F

3M4

Price

€154.203

+0.34%

Cap

€9.34B

Earnings

—

30d Trend

+2.3%

3M4
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

51% annualised over 90 days

BRAIN47 SIGNAL

0
MODERATE
Risk Level55
Quality57
Momentum71
Technical54
Fundamentals41

Raw weighted: 54×Macro 0.99 (−1%)=53

RISK

55/100
90d Volatility
51.1%High
ATR %
0.2%Low daily moves
Max Drawdown (1Y)
-25.9%Normal

QUALITY

57/100
ROE (avg)
-21.0%Negative
Piotroski F-Score
6/9Average
Debt/Equity
0.73Moderate
Margin Stability
CV 9.9%Stable
Accruals
-21.7%Cash earnings
Interest Coverage
6.2xAdequate

MOMENTUM

71/100
12-1M Momentum
+13.7%Strong uptrend
6-1M Momentum
+25.3%Positive
1M Return
-0.0%Stable
Relative Strength
+1.5% vs sectorIn-line

TECHNICAL

54/100
RSI (14)
53.8Neutral
Price vs SMA200
+15.3%Bullish trend
MACD
-0.11Bearish momentum
Bollinger Band
36%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.004Noisy/choppy

FUNDAMENTALS

41/100
EV/EBIT
31.2Expensive
P/FCF
46.9Expensive
P/S
6.1Fair
Shareholder Yield
3.9%Moderate

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months44
3-12 months ★70
1-5+ years54

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate Masimo Corporation at 53/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 71/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

-0.0%

3 MONTHS

+1.8%

12 MONTHS

+13.7%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Momentum (71) and Quality (57) are the primary strengths. I note that fundamentals is the weakest area at 41/100 — this warrants monitoring. Historical volatility is elevated at 51%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 53/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.